Explore the benefits and challenges of long-acting injectables (LAIs) in managing schizophrenia for improved patient outcomes.
Melissa Malinoski, PA-C
Advertisement
Articles by Melissa Malinoski, PA-C
Advertisement
Latest Updated Articles
Advantages of LAIs Over Daily Oral MedicationsSeptember 8th 2025
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
3
Why Some Patients Do Not Respond to GLP-1 Therapies
4
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
5